Studies of cancer patients treated with acridine derivative (C-283). V. Lactate dehydrogenase of serum, leukocytes and erythrocytes.
D000166:Acridines / Q000008:administration & dosage / Q000627:therapeutic use*; D001797:Blood Protein Electrophoresis; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007527:Isoenzymes / Q000032:analysis; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D007962:Leukocytes / Q000201:enzymology*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000201:enzymology*
D000166:Acridines; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase